136 related articles for article (PubMed ID: 30056000)
1. Thrombolysis with rt-PA under Rivaroxaban Anticoagulation in a Hypertensive Rat Model of Intraluminal Middle Cerebral Artery Occlusion.
Izuma H; Oka F; Ishihara H; Inoue T; Suehiro E; Nomura S; Suzuki M
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2761-2767. PubMed ID: 30056000
[TBL] [Abstract][Full Text] [Related]
2. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with rivaroxaban.
Ishihara H; Torii H; Imoto H; Oka F; Sadahiro H; Suzuki M
J Stroke Cerebrovasc Dis; 2014; 23(10):e457-e459. PubMed ID: 25280819
[TBL] [Abstract][Full Text] [Related]
3. Rivaroxaban and apixaban reduce hemorrhagic transformation after thrombolysis by protection of neurovascular unit in rat.
Kono S; Yamashita T; Deguchi K; Omote Y; Yunoki T; Sato K; Kurata T; Hishikawa N; Abe K
Stroke; 2014 Aug; 45(8):2404-10. PubMed ID: 24984746
[TBL] [Abstract][Full Text] [Related]
4. Involvement of thrombolysis in recombinant tissue plasminogen activator-induced cerebral hemorrhages and effect on infarct volume and postischemic endothelial function.
Gautier S; Petrault O; Gele P; Laprais M; Bastide M; Bauters A; Deplanque D; Jude B; Caron J; Bordet R
Stroke; 2003 Dec; 34(12):2975-9. PubMed ID: 14615621
[TBL] [Abstract][Full Text] [Related]
5. The role of connexin43 in hemorrhagic transformation after thrombolysis in vivo and in vitro.
Yang X; Chu H; Tang Y; Dong Q
Neuroscience; 2016 Aug; 329():54-65. PubMed ID: 27138645
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.
Cai Y; Liu X; Chen W; Wang Z; Xu G; Zeng Y; Ma Y
Exp Neurol; 2015 Apr; 266():120-6. PubMed ID: 25708985
[TBL] [Abstract][Full Text] [Related]
7. Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats.
Copin JC; Gasche Y
Brain Res; 2008 Dec; 1243():161-6. PubMed ID: 18835259
[TBL] [Abstract][Full Text] [Related]
8. tPA Mobilizes Immune Cells That Exacerbate Hemorrhagic Transformation in Stroke.
Shi K; Zou M; Jia DM; Shi S; Yang X; Liu Q; Dong JF; Sheth KN; Wang X; Shi FD
Circ Res; 2021 Jan; 128(1):62-75. PubMed ID: 33070717
[TBL] [Abstract][Full Text] [Related]
9. Hemorrhagic transformation during thrombolytic therapy and reperfusion: effects of age, blood pressure, and matrix metalloproteinases.
Lyden PD
J Stroke Cerebrovasc Dis; 2013 May; 22(4):532-8. PubMed ID: 23453556
[TBL] [Abstract][Full Text] [Related]
10. Reperfusion-associated hemorrhagic transformation in SHR rats: evidence of symptomatic parenchymal hematoma.
Henning EC; Latour LL; Hallenbeck JM; Warach S
Stroke; 2008 Dec; 39(12):3405-10. PubMed ID: 18757286
[TBL] [Abstract][Full Text] [Related]
11. Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience.
Aronowski J; Strong R; Shirzadi A; Grotta JC
Stroke; 2003 May; 34(5):1246-51. PubMed ID: 12690223
[TBL] [Abstract][Full Text] [Related]
12. Safety of low-frequency transcranial ultrasound in permanent middle cerebral artery occlusion in spontaneously hypertensive rats.
Wang Z; Fukuda T; Azuma T; Furuhata H
Cerebrovasc Dis; 2012; 33(1):23-9. PubMed ID: 22133698
[TBL] [Abstract][Full Text] [Related]
13. Safety of early initiation of rivaroxaban or dabigatran after thrombolysis in acute ischemic stroke.
Ritzenthaler T; Derex L; Davenas C; Bnouhanna W; Farghali A; Mechtouff L; Cho TH; Nighoghossian N
Rev Neurol (Paris); 2015 Sep; 171(8-9):613-5. PubMed ID: 25857461
[TBL] [Abstract][Full Text] [Related]
14. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
Allahtavakoli M; Amin F; Esmaeeli-Nadimi A; Shamsizadeh A; Kazemi-Arababadi M; Kennedy D
Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):335-9. PubMed ID: 25899606
[TBL] [Abstract][Full Text] [Related]
15. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.
Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A
Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218
[TBL] [Abstract][Full Text] [Related]
16. Effects of a TAFI-inhibitor combined with a suboptimal dose of rtPA in a murine thromboembolic model of stroke.
Durand A; Chauveau F; Cho TH; Kallus C; Wagner M; Boutitie F; Maucort-Boulch D; Berthezène Y; Wiart M; Nighoghossian N
Cerebrovasc Dis; 2014; 38(4):268-75. PubMed ID: 25401979
[TBL] [Abstract][Full Text] [Related]
17. Reduction of intracerebral hemorrhage by rivaroxaban after tPA thrombolysis is associated with downregulation of PAR-1 and PAR-2.
Morihara R; Yamashita T; Kono S; Shang J; Nakano Y; Sato K; Hishikawa N; Ohta Y; Heitmeier S; Perzborn E; Abe K
J Neurosci Res; 2017 Sep; 95(9):1818-1828. PubMed ID: 28035779
[TBL] [Abstract][Full Text] [Related]
18. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model.
Dijkhuizen RM; Asahi M; Wu O; Rosen BR; Lo EH
Stroke; 2002 Aug; 33(8):2100-4. PubMed ID: 12154270
[TBL] [Abstract][Full Text] [Related]
19. Brain hemorrhages after rt-PA treatment of embolic stroke in spontaneously hypertensive rats.
Brinker G; Pillekamp F; Hossmann KA
Neuroreport; 1999 Jun; 10(9):1943-6. PubMed ID: 10501537
[TBL] [Abstract][Full Text] [Related]
20. Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
Pfeilschifter W; Bohmann F; Baumgarten P; Mittelbronn M; Pfeilschifter J; Lindhoff-Last E; Steinmetz H; Foerch C
Ann Neurol; 2012 May; 71(5):624-33. PubMed ID: 22447744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
